In a blog post today, Jeff Jackson, the new Attorney General of North Carolina, wrote about a recently-revised settlement agreement in the Purdue Pharma / Sackler family opioids lawsuit, one he believes will be amenable to Federal courts approval:
"The bottom line? A lot more money for North Carolina. And, by the terms of the agreement, that money will go almost entirely to anti-addiction programs run by individual cities and counties. It’s being channeled directly into the communities that have been hit hardest, with strict rules that it be used to treat addiction or prevent the next generation from falling into this epidemic."
I asked Perplexity.ai, an AI chatbot platform, whether these funds (if approved) could be used to support research activities such as Dr. Grigson's proposed outpatient study. Here's what it came up with when using DeepSeek's R1 model:
"The proposed $7.4 billion settlement agreement between Purdue Pharma, the Sackler family, and a bipartisan coalition of states is not yet publicly available in full text. However, key details can be pieced together from official announcements and court filings ...
"While the settlement prioritizes opioid treatment, prevention, and recovery programs, its language does not explicitly prohibit or mandate research funding. ...
"Clinical trials like outpatient studies of GLP-1 agonists (e.g., liraglutide) for opioid use disorder could qualify under *treatment innovation* (emphasis added - Aron) if aligned with state-approved abatement strategies. However, this would depend on local guidelines, as the settlement itself does not specify research funding."
Am hoping you might be able to share this with Dr. Grigson and others, in case this might prove promising. Thanks!
Thanks, Nicholas!
In a blog post today, Jeff Jackson, the new Attorney General of North Carolina, wrote about a recently-revised settlement agreement in the Purdue Pharma / Sackler family opioids lawsuit, one he believes will be amenable to Federal courts approval:
https://jeffjacksonnc.substack.com/p/the-funding-freeze
"The bottom line? A lot more money for North Carolina. And, by the terms of the agreement, that money will go almost entirely to anti-addiction programs run by individual cities and counties. It’s being channeled directly into the communities that have been hit hardest, with strict rules that it be used to treat addiction or prevent the next generation from falling into this epidemic."
I asked Perplexity.ai, an AI chatbot platform, whether these funds (if approved) could be used to support research activities such as Dr. Grigson's proposed outpatient study. Here's what it came up with when using DeepSeek's R1 model:
https://www.perplexity.ai/search/where-can-one-find-the-propose-c942.cjaT7O6BianiKleOQ
"The proposed $7.4 billion settlement agreement between Purdue Pharma, the Sackler family, and a bipartisan coalition of states is not yet publicly available in full text. However, key details can be pieced together from official announcements and court filings ...
"While the settlement prioritizes opioid treatment, prevention, and recovery programs, its language does not explicitly prohibit or mandate research funding. ...
"Clinical trials like outpatient studies of GLP-1 agonists (e.g., liraglutide) for opioid use disorder could qualify under *treatment innovation* (emphasis added - Aron) if aligned with state-approved abatement strategies. However, this would depend on local guidelines, as the settlement itself does not specify research funding."
Am hoping you might be able to share this with Dr. Grigson and others, in case this might prove promising. Thanks!